Pharmacogenetics of ugt genes in North African populations.
作者信息
Gaibar M, Novillo A, Romero-Lorca A, Esteban M E, Fernández-Santander A
机构信息
Biomedical and Health Sciences Faculty, Universidad Europea de Madrid, Tajo s/n, 28670, Villaviciosa de Odón, Madrid, Spain.
Faculty of Biology, University of Barcelona, Diagonal 645, 08028, Barcelona, Spain.
出版信息
Pharmacogenomics J. 2018 Sep;18(5):609-612. doi: 10.1038/s41397-018-0034-4. Epub 2018 Jul 31.
Abstract
摘要
相似文献
1
Pharmacogenetics of ugt genes in North African populations.北非人群中尿苷二磷酸葡萄糖醛酸转移酶（UGT）基因的药物遗传学
Pharmacogenomics J. 2018 Sep;18(5):609-612. doi: 10.1038/s41397-018-0034-4. Epub 2018 Jul 31.
2
Rosuvastatin pharmacogenetics in African populations.非洲人群中的瑞舒伐他汀药物遗传学。
Pharmacogenomics. 2018 Dec;19(18):1373-1375. doi: 10.2217/pgs-2018-0168. Epub 2018 Nov 6.
3
Usefulness of COMT gene polymorphisms in North African populations.北非人群 COMT 基因多态性的有用性。
Gene. 2019 May 15;696:186-196. doi: 10.1016/j.gene.2019.02.021. Epub 2019 Feb 18.
4
Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.埃塞俄比亚南部人群基因变异的临床和药物基因组学意义
Pharmacogenomics J. 2015 Feb;15(1):101-108. doi: 10.1038/tpj.2014.39. Epub 2014 Jul 29.
5
Characterization of haplotype distribution in African populations and comparison with other global populations.分析非洲人群的单体型分布特征，并与其他全球人群进行比较。
Pharmacogenomics. 2022 Sep;23(14):771-782. doi: 10.2217/pgs-2022-0082. Epub 2022 Aug 31.
6
Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.非洲人群 HIV 治疗中 CYP2B6、CYP2A6 和 UGT2B7 的药物遗传学：以依非韦伦和奈韦拉平为例。
Drug Metab Rev. 2015 May;47(2):111-23. doi: 10.3109/03602532.2014.982864. Epub 2014 Nov 13.
7
Characterization of the genetic profile of CYP2C19 in two South African populations.分析两个南非人群 CYP2C19 的基因谱特征。
Pharmacogenomics. 2010 Aug;11(8):1095-103. doi: 10.2217/pgs.10.90.
8
Cytochrome P450 pharmacogenetics in African populations.细胞色素 P450 药物遗传学在非裔人群中的应用。
Drug Metab Rev. 2013 May;45(2):253-75. doi: 10.3109/03602532.2013.783062. Epub 2013 Apr 16.
9
Extremely high prevalence of DNASE1*1 allele in African populations.非洲人群中DNASE1*1等位基因的极高流行率。
Cell Biochem Funct. 2008 Mar-Apr;26(2):151-3. doi: 10.1002/cbf.1414.
10
Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.与假定的祖先源人群相比，非裔美国人ADME基因的遗传多样性增加及其对药物基因组学的影响。
BMC Genet. 2014 May 1;15:52. doi: 10.1186/1471-2156-15-52.
引用本文的文献
1
Case report: Interstitial pneumonitis after initiation of lamotrigine.病例报告：拉莫三嗪起始治疗后发生间质性肺炎。
Front Psychiatry. 2023 Jul 3;14:1203497. doi: 10.3389/fpsyt.2023.1203497. eCollection 2023.
2
Pharmacogenetics of , , and in the Context of HIV Treatments in African Populations.非洲人群中人类免疫缺陷病毒治疗背景下的[具体药物名称1]、[具体药物名称2]和[具体药物名称3]的药物遗传学
J Pers Med. 2022 Dec 5;12(12):2013. doi: 10.3390/jpm12122013.
3
Human OMICs and Computational Biology Research in Africa: Current Challenges and Prospects.非洲人类组学和计算生物学研究：当前的挑战与展望。
OMICS. 2021 Apr;25(4):213-233. doi: 10.1089/omi.2021.0004. Epub 2021 Apr 1.
4
Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors.人源同工型特异性尿苷二磷酸葡萄糖醛酸转移酶的变异性：急性和慢性暴露、多态性和不确定因素的标志物。
Arch Toxicol. 2020 Aug;94(8):2637-2661. doi: 10.1007/s00204-020-02765-8. Epub 2020 May 15.
本文引用的文献
1
Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.儿童中UGT2B7和UGT1A4基因多态性与抗癫痫药物血清浓度的关联
Med Sci Monit. 2016 Oct 31;22:4107-4113. doi: 10.12659/msm.897626.
2
Tamoxifen metabolism in breast cancer treatment: Taking the focus off the CYP2D6 gene.他莫昔芬在乳腺癌治疗中的代谢：不再聚焦于CYP2D6基因。
Pharmacogenomics J. 2017 Mar;17(2):109-111. doi: 10.1038/tpj.2016.73. Epub 2016 Oct 4.
3
Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects?在非洲推广依非韦伦用于HIV精准医学：我们是否已准备好开展药物警戒并应对神经精神不良反应？
OMICS. 2016 Oct;20(10):575-580. doi: 10.1089/omi.2016.0120. Epub 2016 Sep 14.
4
Cytochrome and sulfotransferase gene variation in north African populations.北非人群中细胞色素和磺基转移酶基因变异
Pharmacogenomics. 2016 Aug;17(13):1415-23. doi: 10.2217/pgs-2016-0016. Epub 2016 Jul 29.
5
Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.葡萄糖醛酸酶基因UGT1A4、UGT2B7、UGT2B15和UGT2B17对乳腺癌患者他莫昔芬代谢的影响。
PLoS One. 2015 Jul 15;10(7):e0132269. doi: 10.1371/journal.pone.0132269. eCollection 2015.
6
Cytochrome P450 pharmacogenetics in African populations: implications for public health.细胞色素 P450 药物遗传学在非裔人群中的研究：对公共卫生的影响。
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):769-85. doi: 10.1517/17425255.2014.894020. Epub 2014 Mar 3.
7
Cytochrome P450 pharmacogenetics in African populations.细胞色素 P450 药物遗传学在非裔人群中的应用。
Drug Metab Rev. 2013 May;45(2):253-75. doi: 10.3109/03602532.2013.783062. Epub 2013 Apr 16.
8
The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.UGT2B17 和 UGT2B28 基因 II 相解毒基因的拷贝数变异对结直肠癌风险的影响。
Cancer. 2013 Jul 1;119(13):2477-85. doi: 10.1002/cncr.28009. Epub 2013 Apr 10.
9
Genetic differences among North African Berber and Arab-speaking populations revealed by Y-STR diversity.Y染色体短串联重复序列（Y-STR）多样性揭示的北非柏柏尔人和说阿拉伯语人群的遗传差异
Ann Hum Biol. 2011 Mar;38(2):228-36. doi: 10.3109/03014460.2010.514862. Epub 2010 Sep 21.
10
Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.奥沙西泮作为 UGT2B15 在体探针的证据：UGT2B15 D85Y 多态性降低奥沙西泮清除率，但 UGT2B17 缺失对其无影响。
Br J Clin Pharmacol. 2009 Nov;68(5):721-30. doi: 10.1111/j.1365-2125.2009.03519.x.
Zotero 插件